Batm Advanced Communicat... Share Discussion Threads

[paulisi] 22/2/2021 09:21

Now the mass selling.I suspect disappointment on the tech side and lack of information on future revenues especially NFV.

[paulisi] 22/2/2021 08:08

Not much reaction from the market so far. Hovering around Friday finish.

[paulisi] 22/2/2021 07:51

Dividend announced, but not defined.Huge growth in medicalLoss on tech side, which I wasn't expecting.Huge potential, but no mention of numbers for NFV.Will the ventilator revenue be repeated?Increased order book on medical.Not sure how the markets will react...

[red5] 22/2/2021 07:46

Amazing results

[babbler] 22/2/2021 07:43

But they plan to leave the UK so :(

[red5] 22/2/2021 07:43

Amazing results

[cumnor] 22/2/2021 07:29

Wow, and a dividend. If it stays UK side will be in the FTSE in a few short years. Right space at the right time.

[emeraldzebra] 22/2/2021 07:24

And dividend confirmed. Was that 109 pct expected ?

[doccash] 22/2/2021 07:17

The Group is receiving significant interest in NFVTime from prospective customers and the pipeline of potential orders continues to expand. NFVTime is currently undergoing evaluation with several leading network operators and multi-service providers worldwide. A number of these evaluations are at an advanced stage and the Group is confident that they will translate to orders in due course.

[wizzkid211] 22/2/2021 07:05

we significantly advanced the execution of our strategy in molecular diagnostics and NFV - our key future growth markets.

[paulisi] 21/2/2021 20:46

Not much happened on TASE - similar to UK pricing from Friday.

[fse] 20/2/2021 22:03

re above post ...... the article is covered in Telecom TV. If you search their website for articles on BATM you get the following. Obviously they rate Telco systems.

[doccash] 19/2/2021 20:17

hxxps://www.telecomtv.com/content/digital-platforms-services/nvidia-s-purchase-of-arm-now-looks-unlikely-without-significant-conditions-40839/

Interesting update sale of Arm

[paulisi] 19/2/2021 17:48

Might be worth keeping an eye on TASE on Sunday. If anything leaks early it will come out of Israel.

[doccash] 19/2/2021 13:46

Remember the results have been preempted so we know the results What we hope for is better guidance going forward.We have had good upturn in price short term Hopefully news on new contracts would continue the rise
Remember FSEs post with comparable diagnostic companies with much better valuations This is where we are heading

[nellyb] 19/2/2021 12:56

Yep, lets not expect something on Monday and being disappointed when it isn't mentioned.

[vago] 19/2/2021 12:43

Fully agree Wizz, Monday is just a step on the path.

[wizzkid211] 19/2/2021 12:26

It hardly makes any difference, if it doesn't happen on Monday it will happen for sure in the next 6 months, BATM is a solid sure bet and would get to 2 quid soon! GOOD LUCK ALL

[milanr] 19/2/2021 11:39

Yes, for sure, member since 08/2020 and so far only 4 posts. Great experience .

[cliff007] 19/2/2021 11:02

Yes, as a shareholder for 20+ years and based on prior experiences it's likely to be a disappointment. 🤪 But hopefully I'm wrong and all the wonderful predictions prove to be conservative ! Bon chance.

[milanr] 19/2/2021 10:10

Yes, share price 150 to 170 at least .

[paulisi] 19/2/2021 09:56

All eyes on the final results on Monday, which we have a good idea about from the trading update and in particular the outlook statement.We should see a dividend announcementWe should get some detailed information on the NFV sales, which is the huge growth area.Will we get anything on the splitting out of divisions, the possible listing on the NASDAQ?We might also see some of the cash from NGSoft sale going towards increasing the stake in Ador again.They may be another bolt on via the medical side. We know BATM have collaborations with a few companies and institutions.Any thoughts?

[wizzkid211] 18/2/2021 17:46

hxxps://www.telco.com/solutions/cloud-networking?fbclid=IwAR1lrreL9YcE_urEXq8SsBTApwV9mVgXvc1Xu0d51UumKHq6_dl9gASpCeg

[doccash] 18/2/2021 15:24

Watching science and technology Covid select committee Sir John Bell presenting evidence He thinks the best way forward going out of lockdown involves regular home testing(twice weekly) of large numbers of the population. They are evaluating a number of tests in their pilots etc. We know that BATM are not involving UK in their sales but that is irrelevant. The main factor is that UK with excellent genomic sequencing will be a front runner on best practice. Hence BATM market for covid testing will continue to grow whatever the impact of the vaccination campaign. He also commented on lab testing for throat infections as a comparison to covid testing and the issue of delay for lab based testing. I think we know a company that has an answer to that problem as well.